Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Gut Microbiota-Derived Immune Response in Chronic Liver Disease
Sung‐Min Won, Eunju Park, Jin‐Ju Jeong, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8309-8309
Open Access | Times Cited: 18

Showing 18 citing articles:

Role of Immune Cells and Receptors in Cancer Treatment: An Immunotherapeutic Approach
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Arunraj Namachivayam, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1493-1493
Open Access | Times Cited: 33
A critical review of microbiome-derived metabolic functions and translational research in liver diseases
Raja Ganesan, Durairaj Thirumurugan, Saranya Vinayagam, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Radiotherapy-Induced Digestive Injury: Diagnosis, Treatment and Mechanisms
Guangxia Chen, Yi Han, Haihan Zhang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 32
From Non-Alcoholic Fatty Liver Disease to Liver Cancer: Microbiota and Inflammation as Key Players
Avilene Rodríguez‐Lara, Ascensión Rueda‐Robles, María José Sáez‐Lara, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 940-940
Open Access | Times Cited: 13
The Gut–Liver Axis in Chronic Liver Disease: A Macrophage Perspective
Kevin De Muynck, Bart Vanderborght, Hans Van Vlierberghe, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 2959-2959
Open Access | Times Cited: 30
The Interaction between the Gut Microbiome and Bile Acids in Cardiometabolic Diseases
Cengiz Callender, Ilias Attaye, Max Nieuwdorp
Metabolites (2022) Vol. 12, Iss. 1, pp. 65-65
Open Access | Times Cited: 20
Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease
Ji Ye Hyun, Seul Ki Kim, Sang Jun Yoon, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8749-8749
Open Access | Times Cited: 16
Metabolic dysfunction-associated steatotic liver disease: A pathophysiology and clinical framework to face the present and the future
Salvatore Corrao, Luigi Calvo, Walter Granà, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024) Vol. 35, Iss. 2, pp. 103702-103702
Closed Access | Times Cited: 3
Gut microbiota involved in myocardial dysfunction induced by sepsis
Kaihao Xiao, Yan Sun, Jiayu Song, et al.
Microbial Pathogenesis (2023) Vol. 175, pp. 105984-105984
Closed Access | Times Cited: 6
Coix Seed Consumption Affects the Gut Microbiota and the Peripheral Lymphocyte Subset Profiles of Healthy Male Adults
Minami Jinnouchi, Taisei Miyahara, Yoshio Suzuki
Nutrients (2021) Vol. 13, Iss. 11, pp. 4079-4079
Open Access | Times Cited: 15
Gut microbiome and metabolic response in non-alcoholic fatty liver disease
Asmita Madatali Abuwani, Shweta Priyadarshini Dash, Raja Ganesan, et al.
Clinica Chimica Acta (2021) Vol. 523, pp. 304-314
Closed Access | Times Cited: 13
Predictive and Prognostic Roles of Gut Microbial Variation in Liver Transplant
Hon Jen Wong, Wen Hui Lim, Cheng Han Ng, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 8
Hepatitis B virus suppresses complement C9 synthesis by limiting the availability of transcription factor USF-1 and inhibits formation of membrane attack complex: implications in disease pathogenesis
Ayana Baidya, Mousumi Khatun, Rajiv Kumar Mondal, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 8
Extrahepatic factors in hepatic immune regulation
Shaoying Zhang, Shemin Lu, Zongfang Li
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Therapeutic Potential of Human Microbiome-Based Short-Chain Fatty Acids and Bile Acids in Liver Disease
Raja Ganesan, Ki Tae Suk
Livers (2022) Vol. 2, Iss. 3, pp. 139-145
Open Access | Times Cited: 7
Eumelanin protects the liver against diethylnitrosamine-induced liver injury
Fikret Altındağ, Seda Boğokşayan, Sinan Bayram
Toxicology (2022) Vol. 480, pp. 153311-153311
Closed Access | Times Cited: 5
Effects of amount of lactose in milk replacer on gastrointestinal function of dairy calves
Rika Fukumori, Takahiro Nakayama, Masaki Hirose, et al.
Animal Feed Science and Technology (2024), pp. 116157-116157
Closed Access
Editorial of Special Issue “The Interplay of Microbiome and Immune Response in Health and Diseases—2nd Edition”
Amedeo Amedei
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7169-7169
Open Access
Page 1

Scroll to top